Compare NPO & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPO | IRTC |
|---|---|---|
| Founded | 2002 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 4.8B |
| IPO Year | 2002 | 2016 |
| Metric | NPO | IRTC |
|---|---|---|
| Price | $256.77 | $139.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 13 |
| Target Price | ★ $278.33 | $209.69 |
| AVG Volume (30 Days) | 213.8K | ★ 640.0K |
| Earning Date | 05-19-2026 | 05-25-2026 |
| Dividend Yield | ★ 0.48% | N/A |
| EPS Growth | N/A | ★ 61.71 |
| EPS | ★ 1.91 | N/A |
| Revenue | ★ $1,532,000,000.00 | $747,138,000.00 |
| Revenue This Year | $9.86 | $18.26 |
| Revenue Next Year | $8.60 | $15.44 |
| P/E Ratio | $139.66 | ★ N/A |
| Revenue Growth | 16.98 | ★ 26.24 |
| 52 Week Low | $133.50 | $92.52 |
| 52 Week High | $286.35 | $210.01 |
| Indicator | NPO | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 48.34 | 39.05 |
| Support Level | $210.31 | $133.25 |
| Resistance Level | $286.35 | $153.57 |
| Average True Range (ATR) | 11.30 | 7.64 |
| MACD | -1.92 | -0.65 |
| Stochastic Oscillator | 3.06 | 19.85 |
Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through three segments: Sealing Technologies, which derives maximum revenue, manufactures and markets sealing products, wheel-end components & systems; and Advanced Surface Technologies manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.
iRhythm Holdings Inc formerly, iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.